GlassScriptPhysician profile
Christopher R Jones
NPI 1669649067
$6,485.52
in general payments reported to CMS, 2019-2025
35 companies · $1,094 in 2025
The $1,094 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $692 · 2020: $608 · 2021: $1,076 · 2022: $752 · 2023: $515 · 2024: $1,748 · 2025: $1,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,879 · Travel and Lodging: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,878.72 |
| Travel and Lodging | $478.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,593.24 | 2019-2024 | Xarelto |
| Penumbra, INC. | $730.08 | 2024 | Indigo System |
| Novartis Pharmaceuticals Corporation | $635.77 | 2019-2025 | |
| Amgen INC. | $548.91 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $346.86 | 2019-2025 | |
| Inari Medical, INC. | $325.15 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $307.80 | 2022-2025 | Harmony, Onyx Frontier, Symplicity G3 |
| Kiniksa Pharmaceuticals International, Plc | $260.97 | 2024 | Arcalyst |
| Abiomed | $210.71 | 2022-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $194.05 | 2019-2025 | Brilinta, Lokelma |
| E.R. Squibb & Sons, L.L.C. | $176.10 | 2021-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $174.38 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $136.42 | 2019-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $93.16 | 2025 | Onpattro |
| Actelion Pharmaceuticals US, INC. | $80.57 | 2021-2025 | Opsumit, Uptravi, Opsynvi |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $67.81 | 2022 | |
| Shockwave Medical, INC | $60.80 | 2025 | |
| Novo Nordisk INC | $56.01 | 2022-2025 | Wegovy |
| Philips North America LLC | $53.94 | 2023-2025 | Coronary Other, (Br5) Peripheral Ivus |
| Terumo Medical Corporation | $46.88 | 2021-2025 | Angio-Seal |
| Kestra Medical Technology Services, INC. | $46.59 | 2023 | Assure Wcd |
| Merck Sharp & Dohme LLC | $43.09 | 2021-2023 | Verquvo |
| Impulse Dynamics (USA) INC. | $43.05 | 2024 | Optimizer |
| Cardiva Medical, INC. | $37.94 | 2025 | Optowire |
| Watermark Medical, INC. | $35.66 | 2025 | |
| Boston Scientific Corporation | $28.47 | 2025 | Varithena Administration Pack |
| Scpharmaceuticals INC. | $24.84 | 2025 | |
| Amarin Pharma, INC. | $22.31 | 2019 | |
| Sanofi-Aventis U.S. LLC | $19.32 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $19.26 | 2023 | Arcalyst |
| Abbott Laboratories | $19.00 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $18.54 | 2019 | |
| Medicomp INC | $13.81 | 2025 | Telepatch Cardiac Monitor |
| Bardy Diagnostics, INC. | $11.00 | 2020 | |
| Cardiovascular Systems INC. | $3.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.